NO20020303L - Flerdose-erytropoietinpreparater - Google Patents

Flerdose-erytropoietinpreparater

Info

Publication number: NO20020303L
Authority: NO; Norway
Prior art keywords: dose erythropoietin; dose; erythropoietin; formulations; phenoxyethanol
Prior art date: 1999-07-22

Application number

NO20020303A

Other languages

English (en)

Norwegian (no)

Other versions

NO20020303D0 (no

Inventor

Atef Gayed

Original Assignee

Aventis Pharma Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-07-22

Filing date

2002-01-21

Publication date

2002-03-21

2002-01-21 Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc

2002-01-21 Publication of NO20020303D0 publication Critical patent/NO20020303D0/no

2002-03-21 Publication of NO20020303L publication Critical patent/NO20020303L/no

Links

102000003951 Erythropoietin Human genes 0.000 title abstract 2
108090000394 Erythropoietin Proteins 0.000 title abstract 2
229940105423 erythropoietin Drugs 0.000 title abstract 2
OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 title abstract 2
WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 abstract 2
238000009472 formulation Methods 0.000 abstract 2
239000000203 mixture Substances 0.000 abstract 2
QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 abstract 1
UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 abstract 1
229960001950 benzethonium chloride Drugs 0.000 abstract 1
238000007911 parenteral administration Methods 0.000 abstract 1
229960005323 phenoxyethanol Drugs 0.000 abstract 1
229940067107 phenylethyl alcohol Drugs 0.000 abstract 1
239000003755 preservative agent Substances 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
- A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Oil, Petroleum & Natural Gas (AREA)
Gastroenterology & Hepatology (AREA)
Zoology (AREA)
Immunology (AREA)
Dermatology (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Hematology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Peptides Or Proteins (AREA)

NO20020303A 1999-07-22 2002-01-21 Flerdose-erytropoietinpreparater NO20020303L (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US19821699P	1999-07-22	1999-07-22
PCT/US2000/040446 WO2001007075A2 (en)	1999-07-22	2000-07-21	Multi-dose erythropoietin formulations

Publications (2)

Publication Number	Publication Date
NO20020303D0 NO20020303D0 (no)	2002-01-21
NO20020303L true NO20020303L (no)	2002-03-21

Family

ID=22732468

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20020303A NO20020303L (no)	1999-07-22	2002-01-21	Flerdose-erytropoietinpreparater

Country Status (25)

Country	Link
US (1)	US7432360B2 (sr)
EP (1)	EP1200115B9 (sr)
JP (1)	JP2003517462A (sr)
KR (1)	KR100693263B1 (sr)
CN (2)	CN101091792A (sr)
AT (1)	ATE304863T1 (sr)
AU (1)	AU777397B2 (sr)
BR (1)	BR0012667A (sr)
CA (1)	CA2378945C (sr)
CZ (1)	CZ302750B6 (sr)
DE (1)	DE60022759T2 (sr)
DK (1)	DK1200115T3 (sr)
EA (1)	EA006220B1 (sr)
EE (1)	EE200200037A (sr)
ES (1)	ES2248110T3 (sr)
HK (1)	HK1050318A1 (sr)
HR (1)	HRP20020159B1 (sr)
HU (1)	HUP0202246A3 (sr)
IL (2)	IL147755A0 (sr)
NO (1)	NO20020303L (sr)
NZ (1)	NZ516735A (sr)
PL (1)	PL202945B1 (sr)
RS (1)	RS50355B (sr)
WO (1)	WO2001007075A2 (sr)
ZA (1)	ZA200200742B (sr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
YU4602A (sh)	1999-07-22	2005-06-10	Aventis Pharmaceuticals Inc.	Farmaceutske formulacije zaštićene od dejstva mikroorganizama
PL219131B1 (pl)	2000-05-15	2015-03-31	Hoffmann La Roche	Ciekła kompozycja farmaceutyczna, sposób jej wytwarzania oraz jej zastosowanie
US7148211B2 (en)	2002-09-18	2006-12-12	Genzyme Corporation	Formulation for lipophilic agents
KR20070015549A (ko) *	2004-03-26	2007-02-05	얀센 파마슈티카 엔.브이.	에리트로포이에틴의 병용 용량요법
US7772182B2 (en)	2004-08-05	2010-08-10	Alza Corporation	Stable suspension formulations of erythropoietin receptor agonists
WO2006081969A1 (de) *	2005-02-03	2006-08-10	Clariant Produkte (Deutschland) Gmbh	Konservierungsmittel
JP2011116752A (ja) *	2009-10-29	2011-06-16	Jcr Pharmaceuticals Co Ltd	エリスロポエチン含有水性液剤
KR101805087B1 (ko) *	2010-09-16	2017-12-05	주식회사 엘지화학	높은 방부력을 제공하는 오일 주사 제형
EP3364944B1 (en) *	2015-10-22	2024-06-12	Iltoo Pharma	Pharmaceutical compositions of il-2

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3489837A (en) *	1968-07-11	1970-01-13	Leroy J Hyman	Synergistic antiseptic composition consisting of 9-aminoacridine hydrochloride and benzethonium chloride
JPS6045849B2 (ja)	1980-08-25	1985-10-12	林原健	ヒトエリトロポエチンの製造方法
US4703008A (en)	1983-12-13	1987-10-27	Kiren-Amgen, Inc.	DNA sequences encoding erythropoietin
JPS6191131A (ja) *	1984-10-09	1986-05-09	Chugai Pharmaceut Co Ltd	医薬品の吸着防止方法および組成物
JPS6197229A (ja)	1984-10-18	1986-05-15	Chugai Pharmaceut Co Ltd	安定なエリトロポエチン製剤
JPH0651637B2 (ja) *	1985-03-28	1994-07-06	エーザイ株式会社	ペプタイドの吸着防止組成物
US5045529A (en) *	1989-03-27	1991-09-03	Bionostics, Inc.	Tonometric fluid for blood gas and co-oximetry instruments
JP3249147B2 (ja) *	1990-06-01	2002-01-21	キリン−アムジエン・インコーポレーテツド	生理活性蛋白含有経口製剤
CA2050425A1 (en) *	1990-09-03	1992-03-04	Yoshiaki Uda	Pharmaceutical composition and its mucous use
DE4126983A1 (de) *	1991-08-15	1993-02-18	Boehringer Mannheim Gmbh	Verfahren zur herstellung von humanprotein-enthaltenden, konservierten arzneimitteln fuer infusions- oder injektionszwecke
US5661125A (en)	1992-08-06	1997-08-26	Amgen, Inc.	Stable and preserved erythropoietin compositions
JP2532025B2 (ja) *	1993-07-23	1996-09-11	株式会社林原生物化学研究所	新リンホカインｉｉｉを有効成分とする抗腫瘍作用を有するリンホカインの活性増強剤
WO1995033474A1 (en) *	1994-06-03	1995-12-14	Tsumura & Co.	Medicinal composition
JP2000504319A (ja) *	1996-01-19	2000-04-11	イーライ・リリー・アンド・カンパニー	肥満症タンパク質製剤
US6261545B1 (en) *	1996-09-13	2001-07-17	Advanced Medicine Research Institute	Ophthalmic compositions of neurotrophic factors, remedies for optic nerve function disorders and method for treating optic nerve function disorders
JPH1112193A (ja) *	1997-06-19	1999-01-19	Sankyo Co Ltd	ヒトカルシトニン含有水溶液製剤
GB9726555D0 (en) *	1997-12-16	1998-02-11	Smithkline Beecham Plc	Vaccine

2000
- 2000-07-21 DK DK00960177T patent/DK1200115T3/da active
- 2000-07-21 PL PL353569A patent/PL202945B1/pl not_active IP Right Cessation
- 2000-07-21 HU HU0202246A patent/HUP0202246A3/hu unknown
- 2000-07-21 AT AT00960177T patent/ATE304863T1/de active
- 2000-07-21 CA CA2378945A patent/CA2378945C/en not_active Expired - Fee Related
- 2000-07-21 WO PCT/US2000/040446 patent/WO2001007075A2/en not_active Ceased
- 2000-07-21 EP EP00960177A patent/EP1200115B9/en not_active Expired - Lifetime
- 2000-07-21 RS YUP-47/02A patent/RS50355B/sr unknown
- 2000-07-21 HK HK03102133.1A patent/HK1050318A1/zh unknown
- 2000-07-21 NZ NZ516735A patent/NZ516735A/en not_active IP Right Cessation
- 2000-07-21 ES ES00960177T patent/ES2248110T3/es not_active Expired - Lifetime
- 2000-07-21 IL IL14775500A patent/IL147755A0/xx unknown
- 2000-07-21 HR HR20020159A patent/HRP20020159B1/xx not_active IP Right Cessation
- 2000-07-21 KR KR1020027000944A patent/KR100693263B1/ko not_active Expired - Fee Related
- 2000-07-21 CZ CZ20020264A patent/CZ302750B6/cs not_active IP Right Cessation
- 2000-07-21 AU AU71374/00A patent/AU777397B2/en not_active Ceased
- 2000-07-21 EE EEP200200037A patent/EE200200037A/xx unknown
- 2000-07-21 DE DE60022759T patent/DE60022759T2/de not_active Expired - Lifetime
- 2000-07-21 BR BR0012667-5A patent/BR0012667A/pt not_active IP Right Cessation
- 2000-07-21 CN CNA2006100710932A patent/CN101091792A/zh active Pending
- 2000-07-21 JP JP2001511958A patent/JP2003517462A/ja active Pending
- 2000-07-21 EA EA200200073A patent/EA006220B1/ru not_active IP Right Cessation
- 2000-07-21 CN CN00812138A patent/CN1371284A/zh active Pending
2002
- 2002-01-21 IL IL147755A patent/IL147755A/en not_active IP Right Cessation
- 2002-01-21 NO NO20020303A patent/NO20020303L/no not_active Application Discontinuation
- 2002-01-28 ZA ZA200200742A patent/ZA200200742B/xx unknown
2005
- 2005-06-27 US US11/167,818 patent/US7432360B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DE60022759T2 (de)	2006-06-22
KR20020011143A (ko)	2002-02-07
EA200200073A1 (ru)	2002-08-29
CZ2002264A3 (cs)	2002-06-12
PL202945B1 (pl)	2009-08-31
DK1200115T3 (da)	2006-01-16
HRP20020159B1 (en)	2007-08-31
CZ302750B6 (cs)	2011-10-19
HK1050318A1 (zh)	2003-06-20
HRP20020159A2 (en)	2003-06-30
CA2378945C (en)	2010-02-23
CN1371284A (zh)	2002-09-25
US7432360B2 (en)	2008-10-07
IL147755A0 (en)	2002-08-14
IL147755A (en)	2009-11-18
CA2378945A1 (en)	2001-02-01
CN101091792A (zh)	2007-12-26
ZA200200742B (en)	2003-06-25
DE60022759D1 (de)	2006-02-02
NO20020303D0 (no)	2002-01-21
YU4702A (sh)	2005-06-10
WO2001007075A3 (en)	2001-10-04
EP1200115A2 (en)	2002-05-02
US20050267033A1 (en)	2005-12-01
AU777397B2 (en)	2004-10-14
EA006220B1 (ru)	2005-10-27
AU7137400A (en)	2001-02-13
NZ516735A (en)	2004-01-30
PL353569A1 (en)	2003-12-01
JP2003517462A (ja)	2003-05-27
RS50355B (sr)	2009-11-10
KR100693263B1 (ko)	2007-03-13
ATE304863T1 (de)	2005-10-15
WO2001007075A2 (en)	2001-02-01
EE200200037A (et)	2003-04-15
BR0012667A (pt)	2002-07-02
ES2248110T3 (es)	2006-03-16
HUP0202246A3 (en)	2010-01-28
EP1200115B9 (en)	2006-01-18
EP1200115B1 (en)	2005-09-21
HUP0202246A2 (en)	2002-10-28

Legal Events

Date	Code	Title	Description
2012-08-06	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
MXPA00007404A (es)	2001-02-01	Composiciones de champu estilizantes.
MXPA02004666A (es)	2003-06-24	Gelatinas recombinantes.
DK0895776T3 (da)	2003-08-25	Kosmetisk, lysskærmende præparat
DE60010098D1 (de)	2004-05-27	28-epirapaloge
ID23374A (id)	2000-04-20	Halogenopirimidin
ATE370748T1 (de)	2007-09-15	Erythropoietin derivate
BR0000327B1 (pt)	2008-11-18	cabeÇa de poÇo.
DK1091975T3 (da)	2006-04-18	Ny cyclosporin med forbedret aktivitetsprofil
DK1097173T3 (da)	2008-09-01	Anvendelse af peptider af IL-2 og derivater deraf som terapeutiske midler
EE200200037A (et)	2003-04-15	Mitmeannuselised erütropoetiinipreparaadid
TR199800105A2 (xx)	1998-08-21	Tadlar� kaplanm��, antibakteriyel etkili kinolon t�revlerinin �retimi.
DE69616074D1 (de)	2001-11-22	Ara-c derivate
PT1107793E (pt)	2005-02-28	Conjugados de dextrano-leptina, composicoes farmaceuticas e processos relacionados
DE60026350D1 (de)	2006-04-27	Diaryl piperidyl-pyrrol-derivate als antiprotozoenmittel
ATE241599T1 (de)	2003-06-15	25-hydroxy-16-ene-26,27-bishome-cholecalcerifer l derivate
EA200000875A1 (ru)	2001-10-22	Белки, взаимодействующие с каспазой-8
TR200003203T2 (tr)	2001-03-21	Karboksaldehitin saflaştırılması
DE59803066D1 (de)	2002-03-21	Substituierte benzyloxyimino-verbindungen
MA24582A1 (fr)	1998-12-31	Nouveaux derives de 4-hydroxy-2h-1-(thio) pyran-2-ones, leurs preparations et leurs utilisations comme rodonticides.
AR026890A1 (es)	2003-03-05	Composiciones de tenocitos, preparaciones y utilizaciones
DK1173065T3 (da)	2007-01-08	Anvendelse af cellulosemikrofibriller i fermenterede mælkepræparater
IT1303556B1 (it)	2000-11-14	Procedimento di preparazione di composti del tipoarilamminoalchilidenemalonati.
FR2752699B1 (fr)	1998-10-16	Boitier, du type boitier de maquillage
ES2183543T3 (es)	2003-03-16	Derivado de tiocolchicosida, su preparacion y su aplicacion en terapeutica.
FI981888A0 (fi)	1998-09-04	Vesipitoisten aineiden esim. uutteiden saattaminen puuhun